NCT00304226

Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

A 14 Week Study to Evaluate Effectiveness of a Valsartan Versus an Amlodipine Treatment Strategy in Achieving Blood Pressure Control in Patients With Stage 1 or Stage 2 Hypertension or Uncontrolled on Present Monotherapy

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 1,288 (actual)
• Sponsor: Novartis · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The population for this current study will include stage 1 and stage 2 hypertensive patients who are newly diagnosed or didn't have treatment during the last 3 months and patients who are currently treated but uncontrolled on present monotherapy. The purpose of this study is to evaluate the efficacy of a treatment with valsartan versus a treatment with amlodipine in reaching blood pressure control after 14 weeks of treatment.

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	valsartan
DRUG	amlodipine

Timeline

• Start date: 2006-02-01
• Primary completion: 2007-01-01
• Completion: 2007-01-01
• First posted: 2006-03-17
• Last updated: 2016-11-16

Locations

2 sites across 2 countries: Germany, Switzerland